Is the measurement of placental protein-14 and CA-125 in plasma and uterine flushings useful in the evaluation of peri-menopausal and post-menopausal bleeding?
| Autor: | Susan Laird, Tin-Chiu Li, M. Heatley, M.A. Okon, Caroline F. Dalton |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Adult
medicine.medical_specialty Uterus Adenocarcinoma Pregnancy Proteins Endometrium Andrology Placenta Internal medicine Biomarkers Tumor medicine Humans Prospective Studies Aged Glycoproteins medicine.diagnostic_test business.industry Rehabilitation Obstetrics and Gynecology Middle Aged medicine.disease Endometrial Neoplasms Menopause medicine.anatomical_structure Endocrinology Glycodelin Reproductive Medicine In utero CA-125 Antigen Female Histopathology Uterine Hemorrhage Atrophy business Endometrial biopsy |
| Zdroj: | Scopus-Elsevier |
| ISSN: | 1460-2350 0268-1161 |
| DOI: | 10.1093/humrep/13.10.2895 |
| Popis: | In this prospective study, we examined the possible diagnostic value of the measurement of two endometrial proteins, placental protein-14 (PP14) and CA-125, in the evaluation of pre- and post-menopausal bleeding. Concentrations of these two proteins were measured in plasma and uterine flushings obtained from 139 pre- and post-menopausal women with bleeding problems, and 26 normal post-menopausal control women without bleeding. Endometrial biopsy samples were also obtained for histological study. Concentrations of PP14 in both the plasma and uterine flushings in post-menopausal women were significantly lower (P < 0.001) than those of control pre-menopausal women. In post-menopausal women, the concentrations of PP14 (mean +/- SEM) in both plasma and flushing were significantly higher (P < 0.001) in women with endometrial adenocarcinoma (46.9+/-7.5 ng/ml plasma; 3350+/-1711 ng/ml flushing) than in the controls (7.6+/-1.3 ng/ml plasma; 125+/-27 ng/ml flushing) or in women with post-menopausal bleeding and atrophic endometrium (20.4+/-2.1 ng/ml plasma; 453+/-167 ng/ml flushing). In contrast CA-125 concentrations in plasma and flushings were similar in post-menopausal and pre-menopausal women. Plasma concentrations of CA-125 were higher in post-menopausal women with adenocarcinoma (29.1+/-7.4 IU/ml) than in those with post-menopausal bleeding and atrophic endometrium (21.8+/-2 IU/ml) (P < 0.05) or control post-menopausal subjects (16.1+/-2.1 IU/ml) (P < 0.01). CA-125 concentrations in uterine flushings were not significantly different in any group of post-menopausal women. The results show that concentrations of PP14 are correlated more strongly to endometrial histopathology than those of CA-125 in pre- and post-menopausal women. Elevated PP14 concentrations are also associated with the presence of endometrial adenocarcinoma and may have a potential to be used as a marker for this disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|